Upcoming events
Aenitis will be participating in the Matinale Deeptech on November, 7th
Emmanuel Vincent, our CEO, will participate in the POC Media – Matinale Deeptech: “Les Nouveaux Acteurs des Biothérapies,” organized by the Agence de l’Innovation en Santé and Polepharma at the Paris Santé Cancer Campus on November 7th. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!